Wilson et al. reported that ABCB5 was significantly upregulated in colon and rectal cancer cells and ABCB5+ tumor cells showed apoptosis resistance [83], suggesting that ABCB5 can be a therapeutic target against colon and rectal cancer. The gene discussed is ABCB5; the disease is rectal cancer.